Iranian Journal of Pediatrics

Published by: Kowsar

Progressive Familial Intrahepatic Cholestasis and its Subtypes: The First Report From Iran

Parnia Torfenejad 1 , Bita Geramizadeh 1 , 2 , * , Mahmoud Haghighat 3 , Seyed Mohsen Dahghani 3 , Mojgan Zahmatkeshan 3 , Naser Honar 3 , Mohammadhadi Imanieh 3 and Seyed Ali Malekhosseini 4
Authors Information
1 Department of Pathology, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Department of Hepatobiliary Surgery, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Iranian Journal of Pediatrics: December 2016, 26 (6); e6497
  • Published Online: August 2, 2016
  • Article Type: Research Article
  • Received: April 20, 2016
  • Revised: June 6, 2016
  • Accepted: June 21, 2016
  • DOI: 10.5812/ijp.6497

To Cite: Torfenejad P, Geramizadeh B, Haghighat M, Dahghani S M, Zahmatkeshan M, et al. Progressive Familial Intrahepatic Cholestasis and its Subtypes: The First Report From Iran, Iran J Pediatr. 2016 ; 26(6):e6497. doi: 10.5812/ijp.6497.

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnote
References
  • 1. Jacquemin E, Dumont M, Bernard O, Erlinger S, Hadchouel M. Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease). Eur J Pediatr. 1994; 153(6): 424-8[PubMed]
  • 2. Jacquemin E. Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin Liver Dis. 2000; 4(4): 753-63[PubMed]
  • 3. Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2012; 36 Suppl 1: 26-35[DOI][PubMed]
  • 4. Dehghani SM, Imanieh MH, Haghighat M, Malekpour A, Falizkar Z. Etiology and complications of liver cirrhosis in children:report of a single center from southern iran. Middle East J Dig Dis. 2013; 5(1): 41-6[PubMed]
  • 5. Monajemzadeh M, Tabriz HM, Mahjoub F, Fallahi G, Farahmand F. Liver needle biopsy in Iraninan pediatric patients: diagnostic significance and pattern of liver diseases. Indian J Pathol Microbiol. 2009; 52(1): 10-3[PubMed]
  • 6. Talachian E, Bidari A, Mehrazma M, Nick-khah N. Biopsy-driven diagnosis in infants with cholestatic jaundice in Iran. World J Gastroenterol. 2014; 20(4): 1048-53[DOI][PubMed]
  • 7. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis. 2009; 4: 1[DOI][PubMed]
  • 8. Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology. 2010; 51(5): 1645-55[DOI][PubMed]
  • 9. Gonzales E, Gerhardt MF, Fabre M, Setchell KD, Davit-Spraul A, Vincent I, et al. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gastroenterology. 2009; 137(4): 1310-20[DOI][PubMed]
  • 10. Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001; 120(6): 1448-58[PubMed]
  • 11. Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr. 1987; 111(2): 251-2[PubMed]
  • 12. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology. 2008; 134(4): 1203-14[DOI][PubMed]
  • 13. Stapelbroek JM, van Erpecum KJ, Klomp LW, Houwen RH. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol. 2010; 52(2): 258-71[DOI][PubMed]
  • 14. de Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A. 1998; 95(1): 282-7[PubMed]
  • 15. Mousavi SA, Karami H. Partial internal biliary diversion in progressive familial intrahepatic cholestasis: introduction of a new approach. Hepat Mon. 2014; 14(3): 13549[DOI][PubMed]
  • 16. Evason K, Bove KE, Finegold MJ, Knisely AS, Rhee S, Rosenthal P, et al. Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies. Am J Surg Pathol. 2011; 35(5): 687-96[DOI][PubMed]
  • 17. Paulusma CC, Groen A, Kunne C, Ho-Mok KS, Spijkerboer AL, Rudi de Waart D, et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology. 2006; 44(1): 195-204[DOI][PubMed]
  • 18. Eppens EF, van Mil SW, de Vree JM, Mok KS, Juijn JA, Oude Elferink RP, et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol. 2001; 35(4): 436-43[PubMed]
  • 19. Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology. 1999; 117(6): 1370-9[PubMed]
  • 20. Giovannoni I, Santorelli FM, Candusso M, Di Rocco M, Bellacchio E, Callea F, et al. Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3. Dig Liver Dis. 2011; 43(7): 567-70[DOI][PubMed]
  • 21. Giovannoni I, Callea F, Bellacchio E, Torre G, De Ville De Goyet J, Francalanci P. Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center. PLoS One. 2015; 10(12): 145021[DOI][PubMed]
  • 22. Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, van Eijk MJ, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology. 2004; 40(1): 27-38[DOI][PubMed]
  • 23. Chen HL, Liu YJ, Su YN, Wang NY, Wu SH, Ni YH, et al. Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J Pediatr. 2008; 153(6): 825-32[DOI][PubMed]
  • 24. Chen HL, Chang PS, Hsu HC, Lee JH, Ni YH, Hsu HY, et al. Progressive familial intrahepatic cholestasis with high gamma-glutamyltranspeptidase levels in Taiwanese infants: role of MDR3 gene defect? Pediatr Res. 2001; 50(1): 50-5[DOI][PubMed]
  • 25. Colombo C, Vajro P, Degiorgio D, Coviello DA, Costantino L, Tornillo L, et al. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr. 2011; 52(1): 73-83[DOI][PubMed]
  • 26. El-Guindi MA, Sira MM, Hussein MH, Ehsan NA, Elsheikh NM. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis. Ann Hepatol. 2016; 15(2): 222-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments